Compounds > 4(5)-2-(2,6-dimethylphenyl)ethylimidazole
Page last updated: 2024-09-04

4(5)-2-(2,6-dimethylphenyl)ethylimidazole and Hypertension

4(5)-2-(2,6-dimethylphenyl)ethylimidazole has been researched along with Hypertension in 1 studies

*Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Järvensivu, P; Karjalainen, A; Kurkela, K; Leppäluoto, J; Vakkuri, O; Vuolteenaho, O1

Other Studies

1 other study(ies) available for 4(5)-2-(2,6-dimethylphenyl)ethylimidazole and Hypertension

ArticleYear
Radioimmunoassay for MPV-295, a new antihypertensive drug.
    Scandinavian journal of clinical and laboratory investigation, 1984, Volume: 44, Issue:7

    Topics: Antibodies; Antihypertensive Agents; Humans; Hypertension; Imidazoles; Iodine Radioisotopes; Male; Radioimmunoassay; Thyroglobulin

1984